
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13722093
[patent_doc_number] => 20170372001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => MODELING RIBOSOME DYNAMICS TO OPTIMIZE HETEROLOGOUS PROTEIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 15/541941
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541941 | MODELING RIBOSOME DYNAMICS TO OPTIMIZE HETEROLOGOUS PROTEIN PRODUCTION | Jan 5, 2016 | Abandoned |
Array
(
[id] => 16942194
[patent_doc_number] => 11054424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Cell identification method
[patent_app_type] => utility
[patent_app_number] => 15/538742
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 14361
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538742 | Cell identification method | Dec 16, 2015 | Issued |
Array
(
[id] => 10814062
[patent_doc_number] => 20160160222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'DNA MOLECULES AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/960136
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20851
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960136
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/960136 | DNA molecules and methods | Dec 3, 2015 | Issued |
Array
(
[id] => 13566369
[patent_doc_number] => 20180334732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => COMPOSITIONS AND METHODS FOR HIV QUASI-SPECIES EXCISION FROM HIV-1-INFECTED PATIENTS
[patent_app_type] => utility
[patent_app_number] => 15/529337
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/529337 | COMPOSITIONS AND METHODS FOR HIV QUASI-SPECIES EXCISION FROM HIV-1-INFECTED PATIENTS | Nov 24, 2015 | Abandoned |
Array
(
[id] => 10978397
[patent_doc_number] => 20160175339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY'
[patent_app_type] => utility
[patent_app_number] => 14/951992
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 31526
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14951992
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/951992 | METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY | Nov 24, 2015 | Abandoned |
Array
(
[id] => 15055339
[patent_doc_number] => 10457960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Methods and compositions for targeted genetic modification using paired guide RNAs
[patent_app_type] => utility
[patent_app_number] => 14/948221
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 41
[patent_no_of_words] => 64557
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14948221
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/948221 | Methods and compositions for targeted genetic modification using paired guide RNAs | Nov 19, 2015 | Issued |
Array
(
[id] => 13552643
[patent_doc_number] => 20180327869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => A Method of Screening for Modulation of Cell Signalling Pathways
[patent_app_type] => utility
[patent_app_number] => 15/525803
[patent_app_country] => US
[patent_app_date] => 2015-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525803
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525803 | A Method of Screening for Modulation of Cell Signalling Pathways | Nov 11, 2015 | Abandoned |
Array
(
[id] => 10799496
[patent_doc_number] => 20160145654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'POLYMER PARTICLES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/927233
[patent_app_country] => US
[patent_app_date] => 2015-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 44182
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927233
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/927233 | POLYMER PARTICLES AND USES THEREOF | Oct 28, 2015 | Abandoned |
Array
(
[id] => 10769346
[patent_doc_number] => 20160115502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'NOVEL CHO INTEGRATION SITES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/919300
[patent_app_country] => US
[patent_app_date] => 2015-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14471
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14919300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/919300 | CHO integration sites and uses thereof | Oct 20, 2015 | Issued |
Array
(
[id] => 11850268
[patent_doc_number] => 20170224758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 15/519100
[patent_app_country] => US
[patent_app_date] => 2015-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27847
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/519100 | COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY | Oct 15, 2015 | Abandoned |
Array
(
[id] => 14454583
[patent_doc_number] => 10323244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => LncRNA and oncolytic adenovirus, and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/523422
[patent_app_country] => US
[patent_app_date] => 2015-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7276
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523422
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523422 | LncRNA and oncolytic adenovirus, and application thereof | Oct 13, 2015 | Issued |
Array
(
[id] => 13065817
[patent_doc_number] => 10053683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Intercellular labeling of ligand-receptor interactions
[patent_app_type] => utility
[patent_app_number] => 14/875140
[patent_app_country] => US
[patent_app_date] => 2015-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24081
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875140
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/875140 | Intercellular labeling of ligand-receptor interactions | Oct 4, 2015 | Issued |
Array
(
[id] => 11836317
[patent_doc_number] => 20170218036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'INNATE IMMUNE SYSTEM MODIFICATION FOR ANTICANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/515075
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18116
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515075 | INNATE IMMUNE SYSTEM MODIFICATION FOR ANTICANCER THERAPY | Sep 28, 2015 | Abandoned |
Array
(
[id] => 11994197
[patent_doc_number] => 20170298351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Method For Screening Interfering Molecules'
[patent_app_type] => utility
[patent_app_number] => 15/514386
[patent_app_country] => US
[patent_app_date] => 2015-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13230
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514386 | Method For Screening Interfering Molecules | Sep 27, 2015 | Abandoned |
Array
(
[id] => 11971540
[patent_doc_number] => 20170275694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'SESTRIN ACTIVATORS FOR PREVENTING AND/OR ATTENUATING SKIN AGEING AND/OR HYDRATING THE SKIN AND/OR FOR REGULATING SKIN PIGMENTATION'
[patent_app_type] => utility
[patent_app_number] => 15/511129
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7021
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511129
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511129 | Sestrin activators for preventing and/or attenuating skin ageing and/or hydrating the skin and/or for regulating skin pigmentation | Sep 24, 2015 | Issued |
Array
(
[id] => 14597319
[patent_doc_number] => 10351844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Methods and compositions for treating leber congenital amaurosis
[patent_app_type] => utility
[patent_app_number] => 15/506323
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 20885
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506323 | Methods and compositions for treating leber congenital amaurosis | Aug 26, 2015 | Issued |
Array
(
[id] => 11950648
[patent_doc_number] => 20170254799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Method for Determining the Repair Activity of Non-Homologous End Joining'
[patent_app_type] => utility
[patent_app_number] => 15/310491
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2894
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310491 | Method for determining the repair activity of non-homologous end joining | Aug 17, 2015 | Issued |
Array
(
[id] => 10712743
[patent_doc_number] => 20160058889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING'
[patent_app_type] => utility
[patent_app_number] => 14/823563
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 26603
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14823563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/823563 | PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING | Aug 10, 2015 | Abandoned |
Array
(
[id] => 11994298
[patent_doc_number] => 20170298453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/503375
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35013
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503375 | SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF | Aug 10, 2015 | Abandoned |
Array
(
[id] => 11994298
[patent_doc_number] => 20170298453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/503375
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35013
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503375 | SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF | Aug 10, 2015 | Abandoned |